Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab versus placebo after uncemented total hip arthroplasty
2011-001481-18Phase 2Completed
- Sponsor
- Akademiska sjukhuset
- Start
- Aug 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hip osteoarthritis comparing Prolia with Placebo (2 arms). Primary endpoint: Periprosthetic bone mineral density at 12 months. Started Aug 2011; status: completed.
02
Drugs
denosumab
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on 2011-001481-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001481-18.